Looking for representation in the Actos lawsuit? Our experience, expertise, and resources make Hollis Law the ideal partner.
Actos is a drug used to treat type II diabetes by helping to control blood sugar levels. On June 15, 2011, the FDA issued a Drug Safety Warning indicating an increased risk of bladder cancer associated with individuals taking Actos. In 2015 after a lengthy battle with the manufacturer of Actos, Takeda Pharmaceutical Company agreed to pay $2.4 billion to settle these cases.
f you’ve been affected by this drug, contact us to learn how we can represent you in the Actos lawsuit.
Call the Hollis Law Firm at 1-800-701-3672 if you or a loved one has suffered from damages related to the use of this product. All calls and case evaluations are free and carry no obligation. The Hollis Law Firm works on cases on a contingent fee basis, which means we don’t get paid if you don’t get paid. Call 1-800-701-3672 to speak to one of our trained intake specialist so that your potential claim can be reviewed by an attorney at the Hollis Law Firm. The injuries and damages caused by contaminated products will not be uniform; therefore, claims will need to proceed on an individual basis and not as part of a class action.
Actos is manufactured by Takeda Pharmaceuticals of Japan and is marketed in the U.S. by Eli Lilly & Co. Since pioglitazone, the single active ingredient in Actos, was first approved by the FDA in 1999, doctors have prescribed Actos to millions of diabetes patients.
History of the Case
In its June 2011 warning, the FDA said patients who had used pioglitazone for longer than 12 months showed a 40 percent increase in the risk of developing bladder cancer.
Injuries Related to Product
Signs of bladder cancer include:
- Bloody or reddish urine
- Frequent urination
- An urgent need to urinate
- Urine leakage (incontinence)
- Pain during urination
- Pain in the back or lower abdomen